26 min listen
A Look at Emerging Healthcare Innovations From a Veteran Investor- Gurdane Bhutani, Managing Partner & Co-Founder at MBX Capital
FromRaise the Line
A Look at Emerging Healthcare Innovations From a Veteran Investor- Gurdane Bhutani, Managing Partner & Co-Founder at MBX Capital
FromRaise the Line
ratings:
Length:
31 minutes
Released:
May 17, 2023
Format:
Podcast episode
Description
“The unifying theme across our portfolio is that whatever a company we invest in is building can make a population-level health impact. For us, that means that what they're doing is going to lead to innovation that is ultimately accessible to huge portions of the global population,” says Gurdane Bhutani, co-founder and managing partner of MBX Capital, a venture capital partnership dedicated to investing in early-stage companies focused on big public health problems. As he explains to host Shiv Gaglani, that ambitious mission is focused on three main themes: accumulated environmental exposure (exposome), biosecurity and biodefense, and healthcare infrastructure. “The majority of disease pathogenesis today is environmental in nature, not genetic. So we're looking at companies that are developing exposomic sequencing technologies that help us better understand these environmental exposures.” One such company is using human-relevant tissue models to test for environmental contaminants. Others include a nurse scheduling platform and a firm that’s localizing radiology systems for underdeveloped areas. Bhutani has a track record of investing in interesting and impactful companies in healthcare (in fact, he was an early backer of Osmosis!) so you won’t want to miss his insightful perspective on promising ideas for improving health and healthcare systems.Mentioned in this episode: https://www.mbxcapital.com/
Released:
May 17, 2023
Format:
Podcast episode
Titles in the series (100)
Prisma Health Physicians Create Ventilator Device That Could Save Lives: After seeing Italy confront the grim reality of ventilator rationing, emergency medicine specialist Dr. Sarah Farris wanted to spare physicians and patients in the U.S. the same agonizing choices. Creating a splitting device that would allow one ventilator to serve two patients seemed like a good solution, and in a remarkable sequence of events, thousands of those devices were manufactured and ready for use just a few weeks after she first mentioned the idea. Sarah and her colleagues at Prisma Health, Dr. Marjorie Jenkins and Dr. Peter Tilkemeier, join host Rishi Desai to describe the powerful partnership of medicine, government and industry that made it possible. by Raise the Line